Experimental Treatment of Ebola Virus Disease with Brincidofovir
Experimental Treatment of Ebola Virus Disease with Brincidofovir
About this item
Full title
Author / Creator
for the RAPIDE-BCV trial team , RAPIDE-BCV trial team , Dunning, Jake , Kennedy, Stephen B. , Antierens, Annick , Whitehead, John , Ciglenecki, Iza , Carson, Gail , Kanapathipillai, Rupa , Castle, Lyndsey , Howell-Jones, Rebecca , Pardinaz-Solis, Raul , Grove, Jennifer , Scott, Janet , Lang, Trudie , Olliaro, Piero and Horby, Peter W.
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola vir...
Alternative Titles
Full title
Experimental Treatment of Ebola Virus Disease with Brincidofovir
Authors, Artists and Contributors
Author / Creator
RAPIDE-BCV trial team
Dunning, Jake
Kennedy, Stephen B.
Antierens, Annick
Whitehead, John
Ciglenecki, Iza
Carson, Gail
Kanapathipillai, Rupa
Castle, Lyndsey
Howell-Jones, Rebecca
Pardinaz-Solis, Raul
Grove, Jennifer
Scott, Janet
Lang, Trudie
Olliaro, Piero
Horby, Peter W.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1818049183
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1818049183
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0162199
